Key focus and themes
Watch US tech sector – a few asymmetric trades
In our last Key focus and themes , we highlighted that supports for USD remained intact ( shifting in this direction since 11 September ), but we were watching near-term risks. The surprise to us over the last week was the weakness in US equities, especially in the tech sector (specifically on 14 October). If this trend continues, it could drive a further weakening of USD, namely in the G10 space, while we believe EM/Asia FX generally underperforms on risk negativity/capital outflows. Our discussions with market participants have focused in on issues around CoreWeave (i.e., AI cloud computing and infrastructure technology company driven by Nvidia chips), noting the share price fall and surge in CDS spreads from high levels of debt, large capital spending and consistent net losses.
Do you expect the recent Nasdaq-100 equity index (NDX) selloff to continue over the next three weeks?
- No, NDX to trade higher
- No, NDX to be largely unchanged
- Yes, NDX lower by up to 10%
- Yes, NDX lower by more than 10%
- US tech sector is key in the near term. A further rout could result in a softer USD, especially against G10 FX, while some market stabilization could cause USD/US yields to retrace some of the recent losses. We are also watching US equity flows, energy prices and US/global yields/credit markets.
- Asia FX: We switch our long CNH against a short abridged CFETS basket to short USD/CNH. We maintain high conviction level or 4/5 on long SGD/IDR, and we remain long USD/INR and long USD/THB (both at 3/5).
- G10 FX: We take profit on long USD/CAD and rotate into a long NZD/CAD position (3/5 conviction level). We open a long USD/JPY trade (3/5), as we see increased downside asymmetry; we were stopped out of our short AUD/GBP and short NOK/SEK trades, but both are on watchlist with 2/5 conviction level, as some fundamental reasons remain.
- Asia rates: We maintain max conviction level of 5/5 in receive Mar-1y HK IRS and high conviction level of 4/5 in receive Mar-5y Korea NDIRS. We added a Dec-2s5s India NDOIS flattener to our watchlist with a conviction level of 2/5.
In our medium-term view of a softer USD , we have highlighted that a slowdown in capital inflows into the US (not necessarily outflows) as seen in H1 2025, could raise concerns over the US’ ability to finance its twin deficits (current account and fiscal deficits weare around 3.1% and 5.7% of GDP, respectively, in Q2 2026). We continue to highlight our concerns over the heavy US asset positioning (USD37.4trn as of Q2 2026; US portfolio liabilities), with equity-related risks centered around the tech sector borrowing/capex. We highlighted five other factors that support our medium-term view.
That said, the question is whether the support for CoreWeave from Nvidia’s Jensen Huang (Bloomberg , 15 October) comments end up being just a temporary reprieve – effective because of the size of Nvidia/cash holdings. Huang stated that CoreWeave’s “strength is improving every day” and was “optimistic” with their cost of capital decreasing (Nvidia has ~10% ownership or CoreWeave; Reuters ). However, aside from Nvidia’s verbal support for CoreWeave, we remain cautious on the risk that there could be other corporate pressures emerging in this sector, owing to the high levels of debt issuance/capex spending and with the distressed level of technology loans (i.e., 10% above the SOFR rate) at a substantial 14.8% of total (based on Bloomberg data). This could become the dominant theme for USD, as we experienced after the stronger-than-expected US September core CPI outturn (14 October; 0.3% m-o-m versus consensus 0.2%), which led USD and 10Y US rates higher by 70bp and 15bp, respectively, immediately afterwards, but were quickly reversed as tech fears emerged.
Overall, we see growing risks to USD in the near term, with the most important being the performance of the US tech sector. However, if this proves to be a short-lived event and US tech rallies back, this could lead the USD/US yields retracing higher on: 1) a potential strengthening of foreign inflows into US equity markets. Our measures of foreign inflows via ETFs and mutual funds showed an acceleration into the US since the start of October (1-13 October at USD4.8bn), which then slowed to almost no inflow on 14 October, when the US tech sector faced more significant selling pressure; 2) a still-elevated oil price backdrop, with rising concerns over higher energy prices amid the approach of the winter season, news the US may be considering massive conventional bombing of Iran (CNN , 15 October), more news of Houthi attacks on Saudi Arabia, Iran announcing it will fight to ”force” the enemy to accept its demands ( Bloomberg , 15 October), and Ukraine ordering a resumption of attacks on Russian oil refineries (FT , 16 October); and 3) a potential move higher in US yields (10Y UST ~25bp below the highs in October), as this could increase the pressure on global bond markets again. We note that long-end French bond yields remain elevated, while 10Y OATS-Bund spreads remain near recent highs. Even with some pullback in global yields (ex-France), credit pressures have remained largely unchanged (iTraxx Europe Crossover index remains near highs at ~313bp on 16 October).
Another event to watch in the nearterm is the 20 October vote on the revenue portion of the 2027 France draft budget (process towards the entire budget scheduled on 17 November). Our recent survey suggests that around 60.9% of participants do not expect this to be passed, a likely slight negative EUR event. Our economics team highlights that some opposition parties could vote against the bill and/or, even if the budget is passed ahead via Article 49.3, political risks could escalate.
Strategy: In Asia FX, bad news from MSCI on Indonesia supports our high conviction level of 4/5 on long SGD/IDR. We also believe the recent move lower in USD/INR (policy induced and not a fundamental change) should be faded, and maintain our long USD/INR position (3/5). We remain positive on CNH (long-held view over the past 12 months), but shift to a short USD/CNH position (i.e., sensitive to any USD softness in G10; 3/5 conviction level) from a long CNH basket. In G10 FX, we take profit on our long USD/CAD and rotate into a long NZD/CAD on relative macro and rate spreads (3/5). We also enter a short USD/JPY (3/5) to reflect growing asymmetric risk in this pair, with the upside likely capped by intervention risk fears, but the downside open to potential changes in local investor flows. In Asia rates, we hold a maximum conviction level of 5/5 in receive Mar27-1Y HKD IRS, because of the overpricing in Hong Kong money market rates (i.e., spot USD/HKD is close to 7.85), as well as our view of no Fed hike in October. Our conviction level in receive Mar27-5Y KRW NDIRS is high at 4/5, given more evidence of a K-shaped economy.
Asia FX strategy
We maintain a high conviction level of 4/5 on our long SGD/IDR position, still targeting 14,440 (~4% gains) by end-November. In Indonesia, IDR was one of the main underperformers in AeJ over the past week, with the bulk of the underperformance occurring on 16 October, following MSCI announcement of a consultation on Indonesia’s market status. We believe several global and local factors will continue to weigh heavily on IDR, including: 1) intensifying market concern over Indonesia’s MSCI market status. We have consistently highlighted the potential for a MSCI downgrade of Indonesia to a frontier market as a significant risk factor for IDR. This risk factor has intensified, with MSCI launching a consultation to reclassify Indonesia from Emerging Market to Standalone Market status, which is a status ranked lower than Frontier Market. Notably MSCI wrote (15 October) that Indonesia’s “classification as an Emerging Market [is] no longer appropriate” and a reclassification of Indonesia to Frontier Markets “would not properly recognize the depth of the market problems”. The justification was that “significant concerns remain around market dysfunction, including continued suspected coordinated trading behavior and lack of evidence of meaningful enforcement”. In the event of a downgrade, we estimated foreign equity outflows could reach ~USD8bn . MSCI’s market consultation will conclude by 30 April 2027, and it will announce its decision on or before 30 June 2027. Indonesia FSA responded (Bloomberg , 16 October) that it will continue to engage index providers and investors on this issue; 2) despite our base case, in which BI hike at its policy decision on 21 October, BI Governor Destry may still attempt to be more aligned with the government’s pro-growth stance. Our economics team assigns a 55% likelihood to a 25bp BI hike versus 35% to a hold and the remaining 10% to a 50bp hike (if IDR pressures intensify prior to the meeting). Governor Destry previously (Bloomberg , 28 September) told Indonesian lawmakers that relying only on rate hikes to stablise IDR would lead to a deeper economic slowdown, with every 25bp increase in its policy rate reducing growth by about 0.1pp. Therefore, BI could maintain its preference to use the new FX hedging instruments and FX intervention rather than resumingrate hikes. Overall, we believe it will likely be an uphill task for Governor Destry to re-establish BI policy credibility, as she manages BI’s multiple policy mandate of inflation targeting, FX stability, economic growth and job creation; 3) elevated US and DM yields, with an increased market focus on France’s fiscal and political outlook. The 10y IndoGB-UST yield spread widened to ~2.3% from ~1.9% last week, as negative tech equity sentiment supported a rally in USTs. Nonetheless, the yield spread is still below recent highs of 3.0% on 11 June, making it less attractive for foreign investors to hold IndoGBs. While October MTD foreign bond inflows have been encouraging at USD521mn (to 14 October), it remains to be seen whether this can be sustained; and 4) the confluence of potential credit rating downgrades by Moody's and Fitch, market concerns over government policies , fiscal outlooks and BI independence, a widening basic balance deficit and BI's already-low FX reserve adequacy ratio also a source of significant risk of portfolio outflows and IDR instability in coming months. We note that Indonesia’s fiscal deficit widened by IDR79trn in September to IDR319trn, as total expenditure rose to 32.9% y-o-y from 10.7%, driven by central government spending.
On Singapore, following MAS’s surprising announcement to leave its FX policy settings unchanged, our S$NEER index fell by as much as ~35bp to a 1.3% deviation above the midpoint of the S$NEER policy band. However, S$NEER has since pared back most of the losses to reach ~1.55% deviation currently. We continue to have a positive view on SGD outperformance amid robust local fundamentals, supported by the current 1.25% annualised S$NEER appreciation slope. Indeed, the October 2026 MAS policy statement remained positive on Singapore’s near-term macro outlook, although MAS also expects growth and inflationary pressures to ease through 2027. The statement suggests the MAS is unlikely to tighten FX policy again in coming quarters, but we judge that the door to a further gradual FX policy tightening remains ajar, dependent upon external energy/food and core inflation developments. Admittedly, Singapore’s core inflation has broadly surprised to the downside in recent months, but our economic team’s assessment remains that core inflation should rise sharply in the next few months, owing to pass-through effects from the energy price shock increase (i.e., electricity tariffs were reduced by a smaller-than-expected 10.4% in Q4 and public transport fares will be raised by 7% in late December). Furthermore, we believe it may be too early to conclude that “supply disruptions to energy and food commodities should gradually ease” (MAS , 14 October), owing to the severity of super El Niño and the risk of a further escalation in Middle East tensions between US/Iran and Saudi/Houthis.
On China, we switch our long CNH against the 6-FX abridged CFETS basket to short USD/CNH with a conviction level of 3/5, targeting 6.50 (~3% gains) by end-December . Looking ahead, if G10 FX (e.g., EUR) benefits from a further selloff in US tech equities (see above), we believe a better expression of our long CNH view would be against short USD rather than short the CFETS basket. Furthermore, we note that in October MTD, DXY has strengthened by ~0.36%, but USD/CNH fell by 0.33% to trade below the 6.70 level. Locally, we continue to see several drivers of CNH appreciation: 1) the daily USD/CNY fixing continues to grind lower. The daily USD/CNY fixing fell by a total of 110pips over the past week (i.e., daily average of 22pips), reaching a new year-to-date low of 6.7220. The positive fixing error (actual fix minus model projection) also remained stable at +297pips; 2) exporters’ FX settlement demand should remain robust in coming months. China’s September trade surplus widened further to USD133.5bn, the highest monthly reading on record, bringing the total trade surplus to USD938bn in the first three quarters of 2026. We have also entered a period when onshore corporates may step up their repatriation of FX earnings in Q4. Watch China September FX trade settlement data (20 October); 3) PBOC Governor Pan’s recent keynote speech may provide positive sentiment for RMB assets and RMB. At the annual meeting of the IMF and the World Bank, PBoC Governor Pan said the PBoC will further support global investors’participation in China’s financial markets, promote RMB-denominated bonds as widely accepted collateral globally, support the development of offshore RMB markets and further expand its liquidity management tool (PBoC , 16 October). Similarly in a closed-door event, PBoC Governor Pan highlighted the resilience of Chinese assets and diversification benefit they can bring to the portfolios to the global investors (Bloomberg , 16 October). These comments could support sentiment and potentially attract more foreign inflows into RMB assets; and 4) ongoing foreign pressure for RMB appreciation. China’s trade surplus with the EU widened to record high of USD35bn in September, and the EU and China held high-level economic talks on trade imbalances from 15 to 16 October. Earlier this week, the European union also limited imports of hybrid electric vehicles (HEVs) from China at 350k per annum. Although this development may temporarily ease tense relations between the EU and China, we believe Chinese authorities still face foreign pressure (including from the US) on the trade imbalances and may allow some CNH appreciation. We note the PBoC released a document on its view on the RMB exchange rate (on 8 October 2026), which downplayed market concerns that RMB appreciation could erode exporters’ profit margins.
On India, we initiated (on 14 October ) a long USD/INR position by raising our conviction level on short INR to 3/5 (from 2), targeting 98.5 (~4% gains) by mid-January 2026. On the rationale that we expect the positive impact from recent FX measures to fade, rapid FX reserves drawdown, local flow challenges, US tariff uncertainty and USD bid: 1) we expect the positive impact from the RBI’s latest FX measures to be temporary. INR has appreciated against USD on a spot basis since the RBI announced several INR supportive measures, along with reports of FX intervention (Bloomberg , 12 to 16 October). However, we do not expect the positive impact on INR from these measures to last without a fundamental shift in India’s BOP dynamics. For example, the RBI's tightening of restrictions on FX derivative transactions and increasing long USD hedging costs increase the cost of hedging for those with genuine USD demand and does not help address India’s widening current account deficit; 2) the RBI’s special window for USD purchases by the three public sector OMCs will help to reduce USD demand in the market, with our economics team estimating this measure will reduce USD demand by ~55% of India’s average monthly oil import bill (i.e., ~USD9bn of USD demand a month, out of the USD16.4bn monthly average since April-August 2026). This measure is unlikely to be sustained (it lasted around two months when it was initiated last time in October 2013), and is still small relative to a monthly average trade deficit of ~USD30bn over the past twelve months; 3) as a result, we see a more rapid drawdown in the RBI's spot FX reserves, which could also renew investor concerns. The RBI’s weekly headline FX reserves already fell sharply from the peak of USD648.2bn on 4 September to USD604.7bn as of 2 October. Furthermore, after taking into account the RBI’s large net short forward book, which we estimate at -USD197.8bn in September 2026, the RBI’s FX reserve adequacy (using IMF methodology ) has actually fallen to ~166% in September 2026 from 181% in May 2026; 4) we are still concerned over INR from a BOP flow perspective. Overall, we believe India still faces local flow challenges from the AI/tech developments and high global energy prices; 5) Uncertainty around US-India trade relations. India’s relatively heavy dependence on Russian oil imports still exposes it to the risk of further US tariffs from the Sanctioning Russia and Iran Act of 2026; and 6) global developments still point to a stronger USD (against EM) in the near term . Underlying drivers for USD bid remain from elevated oil/energy prices and risks, bond market pressures remaining in France and the US, relatively strong US equity outperformance and strong portfolio inflows into the US. Specifically, elevated oil prices should exert downward pressure on INR.
On Thailand, we maintain the conviction level on our long USD/THB position at 3/5, targeting 34.5 (~3% gains) by end-November, and implement a stop-loss at 33.16. We continue to see a rationale for spot USD/THB to trade higher in the near term, owing to: 1) BOT apparent tolerance for THB underperformance. We estimate BOT accumulated USD1.4bn (spot and forward) over the week ended 9 October, and THB only strengthened marginally by 0.15% against USD. In comparison, we estimate the BOT net sold USD4.3bn of FXR (spot + forward) in September to lean against THB depreciation pressures, with THB still being the top underperforming AeJ currency in September (-1.2% against USD). During a Reuters interview (17 September), BOT Assistant Governor Don Nakornthab said “a weak baht is good for the Thai economy, as long as it's not too volatile or it does not slide significantly, then I think we are quite happy with what we see in the baht”; 2) we continue to see risk of the USD bid, especially against EM (see above), feeding through to higher USD/THB. Based on weekly returns over the past 12 months, USD/THB has the second highest beta to DXY (after USD/KRW) and the third highest correlation to DXY (after USD/SGD and USD/CNH) within AeJ. We believe USD/THB will remain sensitive to USD bid; 3) Thailand’s capital flow dynamics appear anemic. In October MTD, foreign investors net sold USD300mn of Thai equities, while foreign bond inflows of USD336mn so far appear tentative. Local holdings of foreign currency deposits also rose in July and August by USD1.2bn and USD0.4bn, respectively; and 4) elevated energy prices are a strain on Thailand’s fiscal position. The elevated energy price shock shows few signs of significant easing, which should disproportionately weigh on Thailand, due to its high net energy imports and concentration risk with the Middle East. In addition to having a negative impact on the trade balance, fiscal concerns are also rising with Thailand’s State Oil Fuel Fund facing a severe liquidity crisis. The State Oil Fuel Fund currently runs a deficit of nearly ~THB100bn , almost double the ~THB57bn in mid-June 2026 (Bloomberg , 16 June 2026). The Thai government may reduce the energy subsidy and allow the local retail oil prices to adjust higher slightly, but if pressures continue, they would have to consider other fiscal options, including utilising a tranche of the borrowing decree already designated for domestic investment. Key risks to watch are: a) foreign tourist arrivals, which only pick up more significantly in December and January; and b) the BOT limiting upside volatility in USD/THB.
Separately, we also lower the conviction level on our long TWD/KRW to 0/5 from 2/5, thereby removing it from our watchlist.
G10 FX strategy
Open short USD/JPY trade with increased asymmetry in the pair
We are becoming more optimistic on JPY’s prospects and think risk/reward increasingly favours selling USD/JPY. We open a short USD/JPY trade to reflect this view, with a conviction level of 3/5 and a target of 152.50 by year-end. In our view, risks remains asymmetric from a policy perspective and, while MOF FX intervention may not be imminent, market concerns about such actions will likely become more elevated, should USD/JPY head closer to 160. We also think USD/JPY will remain highly sensitive to any further signs of an AI-led “risk off” move in equity markets. Perhaps more importantly, from a domestic perspective, we are starting to see increased signs, albeit gradual ones, that Japanese market participants could become more positive on JGBs. Recent interview comments (Bloomberg ) from two senior Japanese major bank managers highlighted that both could increase their investment in JGBs, as 10-year JGB yields move into attractive territory. BOJ comments continue to suggest hikes remain on the cards – from Governor Ueda and board member Koeda, for example – and while these are not getting incrementally more hawkish, the ongoing delivery of rate hikes in the months ahead will narrow the JPY’s negative carry differential versus many other G10 currencies and could start to incentivise changes in FX hedging plans into 2027.
Take profit on long USD/CAD and rotate into long NZD/CAD
We take profit on our long USD/CAD trade for a gain of 1.3% (entry 1.3985 on 17 September), as USD starts to run out of steam and with little prospect for October rate hike. We like to maintain an underweight CAD view, however, as we still see little chance of the BoC delivering anything close to the 95bp of rate hikes priced by the market for the year ahead. As such, we open a new long NZD/CAD trade with a target of 0.8280 by year-end with a conviction levelof 3/5. Core inflation measures remain around target, and the labour market has continued to soften, suggesting little risk of strong second-round effects from higher energy prices. The CPI for September will be released on 19 October and seems unlikely to show much of a change on core measures. Meanwhile, we think NZD’s recent underperformance has been less due to local factors and more global. If anything, job growth continues to improve, albeit slowly, and activity surveys remain resilient despite higher energy costs. NZD/CAD has deviated significantly from rate spreads in recent weeks, having shown a strong link over a range of windows, which suggests scope for a catch up, in our view. While an RBNZ rate hike on 28 October is not a done deal, we still think the RBNZ will need to remain cautiously hawkish. Although Q3 inflation (due on 22 October local time) may have moderated on lower fuel prices, these were already rebounding into the end of the quarter, suggesting upside risks to inflation in Q4. As such, a hike before year-end is highly likely, in our view.
EUR: French budget negotiations are front and centre but not decisive this week
The domestic focus for EUR will be French budget negotiations, with a vote due on the revenue side of the bill on 20 October. Regardless of whether this passes, it is not binding for the final budget, and there is a good chance parliament will push this to the Senate this week, which may create some negative jitters for EUR via the OAT-Bund spread. However, we still see ultimate passage of the budget as more likely than not, whether through a direct vote or through the government using special measures (i.e., Article 49.3 or 47), which can effectively push the budget through alongside a confidence vote on the government. We do not think RN (Marine Le Pen’s party) would look to bring down the government this close to the presidential elections (first round 18 April 2027) and risk being seen as a “chaos maker” rather than a legitimate government option. While this should ultimately ease downward pressure on EUR, the risk of volatility in the weeks ahead remains high and, in our view, does not justify opening long EUR positions yet. Speculative positioning has become more stretched to the short side in EUR, and the currency could benefit if US equity market wobbles were to continue around the AI trade.
Short GBP/AUD hits stop on weaker Australia data and risk off sentiment
After seeing signs that the cross was starting to head lower, two data points combined to squeeze the pair higher and hit our stop loss at 1.9150 on Thursday, 15 October. Australia’s labour market data were weak, almost across the board. The unemployment rate rose to 4.7% and there was a decline in employment, albeit concentrated in part-time employment. Market pricing for the RBA now suggests less than a 20% chance of a hike in early November. While Q3 inflation likely remained uncomfortably high (release due 28 October), the RBA may look through this in the face of softening domestic activity data. Meanwhile, and in contrast, UK GDP data for August were a little stronger than expected at 0.1% m-o-m (versus -0.1% expected). This puts UK growth at 1.3% (~2.6% annualised) since the start of the US-Iran war, which is a much more resilient performance than many, including ourselves, expected. A more robust backdrop to activity could give the BoE more comfort in potentially hiking rates, while also providing some modest support around the budget via firmer revenue calculations. This week, the focus turns to employment and inflation in the UK. Any signs of a pickup in wage growth or a faster rise in core or services inflation will likely cement the probability of a BoE November rate hike, although we still think the likelihood of 100bp of tightening being delivered (as implied by market pricing) is low, a view seemingly shared by BoE Chief Economist Huw Pill in comments made at the IMF meetings in Bangkok.
Short NOK/SEK hits stop after US CPI despite little change in local factors
NOK/SEK bounced through our 1.0550 stop level after the release of US inflation data yesterday, as front-end US yields squeezed higher after the stronger-than-expected core CPI print. NOK/SEK’s sensitivity to front-end US rates has pushed towards historical highs. We do not see any direct “fundamental” reasons for this, although the recent relationship between energy prices and front-end rates globally has likely contributed to this shift. Higher energy prices in recent months have supported NOK and pushed yields higher simultaneously, although yesterday’s move in rates occured despite limited upward pressure on commodity prices. We do not see major shifts in domestic factors that would justify a significant move higher in NOK/SEK, and note that the pair has retraced a little to around 1.05 since hitting our stop. As such, we continue to look for opportunities to be short this pair when external factors might be less challenging and volatile, keeping a 2/5 conviction on the pair.
Asia rates strategy
We continue to hold receive positions, in Hong Kong and Korea specifically, with high conviction levels. We believe the market is still overpricing Fed hikes and there is some local support for lower Hong Kong and Korea rates (flush liquidity and weak loan growth in Hong Kong, a K-shape economy and increased equity volatility for Korea). On the other side, we expect Singapore and India rates to underperform. We maintain a moderate conviction pay position in Singapore rates and, in India, we have put a flattener on our watchlist.
Hong Kong: Receive Mar27-1y IRS at a conviction level of 5/5
We have raised our receive H27-1y Hong Kong position to a maximum conviction level of 5/5 this week, targeting a move to 3.80% by end-November (current 4.22%). Key reasons include: 1) our economists’ base case of no change to the fed funds rate in October, despite higher-than-expected inflation prints this week; 2) our view that the market is over-pricing the potential impact on Hong Kong money market rates, even if spot USD/HKD trades to 7.85. Hong Kong liquidity is flush, with the bank loan-to-deposit ratio at a 10y low. We note that Hong Kong banks have kept the prime rate unchanged after the Fed hike and, anecdotally, banks have raised their HKD time deposit rates by much less than the increase in swap rates over the past three months; 3) significant carry as the Hong Kong swap curve is much steeper than the US swap curve across the 6m to 2y point; 4) 3m HIBOR is historically quite stable in October. That said, we acknowledge Fed pricing remains a potential risk, so we also set a reassess level at 4.40% (~18bp from current level).
Korea: Receive Mar27-5y NDIRS at a conviction level of 4/5
We maintain a receive Korea recommendation with a fairly high conviction level, as 1) we see more evidence of a K-shaped economy, with weak IP/real wage growth in September, while MOFE has continued to reduce KTB issuance in October; 2) compared to other AeJ economies with similar yield levels, the BOK was early in hiking, having already done so twice. The pressure to implement additional hikes could be lower without significant FX pressure; 3) the recent drop in the KOSPI may result in some reallocation to KTBs. That said, Mar27-5y NDIRS have already moved ~30bp in the last two weeks and, with the BOK policy meeting next Thursday (even though we expect no change), we could reassess this position should the trade reach our target of 3.90% into the meeting.
Singapore: Keep pay Z26-5y SORA position; conviction level: 3/5
This week, MAS, in its October MPS, delivered a dovish surprise to the market by maintaining the current policy settings, while our base case and market consensus both envisaged a slope steepening. Since the MPS, SGD rates have rallied amid generally stable SORA fixings and currently the trade has reached our re-assess level of 2.25%. We would like to give the trade more time, as local fundamentals do appear supportive, due to recent, strong credit growth and September NODX growth at 68.4% y-o-y. The trade is also at a level where we expect to see some technical support. We therefore maintain the pay Z26-5y position for now and will watch if it convincingly breaks lower. We maintain our assessment that Singapore yield levels could drift higher over the medium term, supported by strong credit growth and low real yields. That said, we acknowledge the trade would likely struggle to perform if liquidity remains flush and SORA fixings stay relatively low.
China rates: Maintain Dec-1s5s steepener (conviction level: 3/5)
This week, China swap rates rallied by ~5bp across the curve, despite mixed economic data (high PPI, in-line CPI, strong export growth and credit growth slightly above consensus). Such moves might look normal for DM and other Asia markets, but are relatively large for China. There are two main reasons behind the rally. Firstly, liquidity turned much looser starting from last Friday (9 October), with DR001 continuing to move lower to ~1.26% latest. Note that DR001 has mostly been in the range of 1.35-1.45% (7d OMO rate 1.40% +/-5bp) from mid-June (Lujiazui Forum) to end-September. Secondly, market expectations for monetary easing are building into the Financial Street Forum next week, where Governor Pan is scheduled to deliver a speech on 19 October. If the PBoC hints that a rate cut is not an option on the table but that it will instead inject more liquidity via different monetary policy tools, rates can still move lower, especially considering the rekindled interesting in (ultra) long-end CGBs by onshore funds (and securities firms’). Thus, we took out our extra pay Dec-5y earlier this week , but hold our recommendation in Dec-1s5s steepener with a moderate conviction level (3/5). In our view, sustainably low funding costs, a narrower DR007-DR001 and R-DR spreads should cap front-end swap rates. On the long end, we see room for underperformance, as government bond supply is set to be much higher than last year (monthly average at RMB1.2trn in Q4 2026 versus RMB730bn in Q4 2025), and 30y CGB positioning is already very crowded (in both cash bonds and futures). Next week, besides Governor Pan’s speech, September activity data and Q3 GDP will also be released on Monday.
India – Preference for flattener positions; conviction level 2/5
We add a Dec-2s5s flattener on our watchlist at a conviction level of 2/5. We like the trade due to the prospect of liquidity draining that could cause the banking system liquidity to swing from surplus to neutral and potentially deficit. The multitude of factors contributing to this drain include 1) festive currency draw 2) monthly GST collections for October (starting 20 October) and 3) continuous RBI spot FX intervention. The RBI so far has also conducted INR1.25trn of OMO sales to mop up liquidity. We only put it on watchlist, as flatteners have a highly negative carry profile (Dec 2s5s -2.7bp/month). Directionally, we were stopped out of our receive Dec-5y NDOIS trade earlier this week. As the RBI is ratcheting up its defense of the currency, we think rates will continue to trade higher, especially in the cash bond space, following recent OMO sales and switching of Gsec. Therefore, we no longer see a strong case to revisit the receive 5y position soon and further lower conviction of receive Dec-5y NDOIS from 2 (watchlist) to 0.
Australia rates: Next week should be more interesting
The minutes from the RBA’s meeting of 29 September were hawkish ; they gave only a brief discussion to the case for a pause, suggested increased sensitivity to rate hikes elsewhere (which could ease financial conditions via a lower AUD) and were more accepting of a higher unemployment rate (likely required to bring inflation down to target). However, the September labour force report was unambiguously weak , even allowing for some potential noise in the data. Our base case remains one in which the RBA rate hike cycle is over, but our suggested probability of a surprise November hike (~30%) is greater than the market is currently pricing (~15%). Another hike would be deeply unpopular (including politically), amid a trend rise in unemployment and trend decline in dwelling prices, but a “hold” would require the RBA to look through a likely uncomfortable Q3 CPI report on 28 October (Nomura forecast 1.25% q-o-q for headline CPI, and 0.96% q-o-q for trimmed mean CPI). Given the rally in rates this week following the local jobs report, and our view around November rate hike pricing, we lower the conviction level in a received AU 6m1y position to 0/5 (was 2/5). Indeed, we currently have some sympathy with the idea of paying Australia 6m1y versus receiving US 6m1y, given our US team’s view for only one final Fed hike, most likely in December. The local calendar is quiet next week, but we will be watching the New Zealand Q3 CPI report; our forecast for headline CPI is currently 0.6% q-o-q (below the RBNZ forecast of 0.8% q-o-q) and our base case (60% probability) remains that the RBNZ will not hike in October (16.5bp currently priced).
Previously, we asked “Do you expect the French National Assembly to pass the vote on the revenue section of the 2027 State Budget Bill scheduled on 20 October? How do you expect EUR/USD in the one session after the vote?”, 43.5 % chose “No, EUR/USD lower by 0-1% ” and 30.4 % chose “Yes, EUR/USD higher by 0-1% ” and 17.4% chose “No, EUR/USD lower by more than 1% ” and 8.7% chose “Yes, EUR/USD higher by more than 1% ”.
Please see Strategy portfolio update (15 October 2026) for our full portfolio.
Appendix A-1
This report has been produced by Nomura Singapore Ltd. (NSL), Singapore. See Disclaimers for Nomura Group entity details.
Analyst Certification
Each research analyst identified herein certifies that all of the views expressed in this report by such analyst accurately reflect his or her personal views about the subject securities and issuers. In addition, each research analyst identified in this report hereby certifies that no part of his or her compensation was, is, or will be, directly or indirectly related to the specific recommendations or views that he or she has expressed in this research report, nor is it tied to any specific investment banking transactions performed by Nomura Securities International, Inc., Nomura International plc or any other Nomura Group company.
Issuer Specific Regulatory Disclosures
The terms "Nomura" and "Nomura Group" used herein refer to Nomura Holdings, Inc. and its affiliates and subsidiaries, including Nomura Securities International, Inc. ('NSI') and Instinet, LLC ('ILLC'), U. S. registered broker dealers and members of SIPC.
| Issuer | Disclosures |
|---|---|
| COMMONWEALTH OF AUSTRALIA | A13 |
| REPUBLIC OF SINGAPORE | A1,A2,A3 |
| REPUBLIC OF KOREA | A1,A2,A3,A4,A5,A6,A13 |
| UNITED STATES OF AMERICA | A13 |
| HONG KONG MONETARY AUTHORITY | A1,A2,A3 |
A1 The Nomura Group has received compensation for non-investment banking products or services from the subject company in the past 12 months. A2 The Nomura Group has had a non-investment banking securities related services client relationship with the subject company during the past 12 months. A3 The Nomura Group has had a non-securities related services client relationship with the subject company during the past 12 months.
A4 The Nomura Group has had an investment banking services client relationship with the subject company during the past 12 months.
A5 The Nomura Group has received compensation for investment banking services from the subject company in the past 12 months.
A6 The Nomura Group expects to receive or intends to seek compensation for investment banking services from the subject company in the next three months. A13 The Nomura Group has a significant financial interest (non-equity) in the issuer.
Important Disclosures
Online availability of research and conflict-of-interest disclosures Nomura Group research is available on www.nomuranow.com/research, Bloomberg, Capital IQ, Factset, LSEG. Important disclosures may be read at http://go.nomuranow.com/research/m/Disclosures or requested from Nomura Securities International, Inc. If you have any difficulties with the website, please email grpsupport@nomura.com for help.
The analysts responsible for preparing this report have received compensation based upon various factors including the firm's total revenues, a portion of which is generated by Investment Banking activities. Unless otherwise noted, the non-US analysts listed at the front of this report are not registered/qualified as research analysts under FINRA rules, may not be associated persons of NSI, and may not be subject to FINRA Rule 2241 restrictions on communications with covered companies, public appearances, and trading securities held by a research analyst account.
Nomura Global Financial Products Inc. (NGFP) Nomura Derivative Products Inc. (NDP) and Nomura International plc. (NIplc) are registered with the Commodities Futures Trading Commission and the National Futures Association (NFA) as swap dealers. NGFP, NDPI, and NIplc are generally engaged in the trading of swaps and other derivative products, any of which may be the subject of this report.
ADDITIONAL DISCLOSURES REQUIRED IN THE U.S.
Principal Trading: Nomura Securities International, Inc and its affiliates will usually trade as principal in the fixed income securities (or in related derivatives) that are the subject of this research report. Analyst Interactions with other Nomura Securities International, Inc. Personnel: The fixed income research analysts of Nomura Securities International, Inc and its affiliates regularly interact with sales and trading desk personnel in connection with obtaining liquidity and pricing information for their respective coverage universe.
Valuation methodology - Fixed Income Nomura’s Fixed Income Strategists express views on the price of securities and financial markets by providing trade recommendations. These can be relative value recommendations, directional trade recommendations, asset allocation recommendations, or a mixture of all three. The analysis which is embedded in a trade recommendation would include, but not be limited to: • Fundamental analysis regarding whether a security’s price deviates from its underlying macro- or micro-economic fundamentals. • Quantitative analysis of price variations. • Technical factors such as regulatory changes, changes to risk appetite in the market, unexpected rating actions, primary market activity and supply/ demand considerations. The timeframe for a trade recommendation is variable. Tactical ideas have a short timeframe, typically less than three months. Strategic trade ideas have a longer timeframe of typically more than three months.
For the purposes of the EU Market Abuse Regulation, the distribution of ratings published by Nomura Global Fixed Income Research is as follows: 54% have been assigned a Buy (or equivalent) rating; 50% of issuers with this rating were supplied material services* by the Nomura Group**. 0% have been assigned a Neutral (or equivalent) rating. 46% have been assigned a Sell (or equivalent) rating; 50% of issuers with this rating were supplied material services by the Nomura Group. As at 30 Sep 2026. *As defined by the EU Market Abuse Regulation **The Nomura Group as defined in the Disclaimer section at the end of this report Disclaimers This publication contains material that has been prepared by the Nomura Group entity identified on page 1 and, if applicable, with the contributions of one or more Nomura Group entities whose employees and their respective affiliations are specified on page 1 or identified elsewhere in this publication. The term "Nomura Group" used herein refers to Nomura Holdings, Inc. and its affiliates and subsidiaries including: (a) Nomura Securities Co., Ltd. ('NSC') Tokyo, Japan, (b) Nomura Financial Products Europe GmbH (‘NFPE’), Germany, (c) Nomura International plc ('NIplc'), UK, (d) Nomura Securities International, Inc. ('NSI'), New York, US, (e) Nomura International (Hong Kong) Ltd. (‘NIHK’), Hong Kong, (f) Nomura Financial Investment (Korea) Co., Ltd. (‘NFIK’), Korea (Information on Nomura analysts registered with the Korea Financial Investment Association ('KOFIA') can be found on the KOFIA Intranet at http://dis.kofia.or.kr, (g) Nomura Singapore Ltd. (‘NSL’), Singapore (Registration number 197201440E, regulated by the Monetary Authority of Singapore) (h) Nomura Australia Ltd. (‘NAL’), Australia (ABN 48 003 032 513), regulated by the Australian Securities and Investment Commission ('ASIC') and holder of an Australian financial services licence number 246412, (i) Nomura Securities Malaysia Sdn. Bhd. (‘NSM’), Malaysia, (j) NIHK, Taipei Branch (‘NITB’), Taiwan, (k) Nomura Financial Advisory and Securities (India) Private Limited (‘NFASL’), Mumbai, India (Registered Address: Ceejay House, Level 11, Plot F, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai- 400 018, India; Tel: 91 22 4037 4037, Fax: 91 22 4037 4111; CIN No: U74140MH2007PTC169116, SEBI Registration No. for Stock Broking activities : INZ000255633; SEBI Registration No. for Merchant Banking : INM000011419; SEBI Registration No. for Research: INH000001014 - Compliance Officer: Ms. Pratiksha Tondwalkar, 91 22 40374904, grievance email: investorgrievancesra@nomura.com Webpage: LINK For reports with respect to Indian public companies or authored by India-based NFASL research analysts: (i) Investment in securities markets is subject to market risks. Read all the related documents carefully before investing. (ii) Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. (iii) NFASL terms and conditions for availing research services is disclosed on NFASL webpage.
(l) Nomura Fiduciary Research & Consulting Co., Ltd. ('NFRC') Tokyo, Japan. (m) Nomura Orient International Securities Co., Ltd (“NOI”), is a majority owned joint venture amongst Nomura Group, Orient International (Holding) Co., Ltd, and Shanghai Huangpu Investment Holding (Group) Co., Ltd. In accordance with the laws of the People’s Republic of China (“PRC”, excluding Hong Kong, Macau and Taiwan, for the purpose of this document), NOI is licensed in the PRC to provide securities research and investment recommendations and it operates independently from the other members of the Nomura Group; in particular, NOI’s interests in PRC securities are not disclosed to, or aggregated with the holdings of, any other Nomura Group entities and the interests in PRC securities of other Nomura Group entities are not disclosed to, or aggregated with the holdings of, NOI. An individual name printed next to NOI on the front page of a research report indicates that individual is employed by NOI to provide research assistance to NIHK under a research partnership agreement. ‘NSFSPL’ next to an employee’s name on the front page of a research report indicates that the individual is employed by Nomura Structured Finance Services Private Limited to provide assistance to certain Nomura entities under inter-company agreements. 'Verdhana' next to an individual's name on the front page of a research report indicates that the individual is employed by PT Verdhana Sekuritas Indonesia ('Verdhana') to provide research assistance to NIHK under a research partnership agreement and neither Verdhana nor such individual is licensed outside of Indonesia. THIS MATERIAL IS: (I) FOR YOUR PRIVATE INFORMATION, AND WE ARE NOT SOLICITING ANY ACTION BASED UPON IT; (II) NOT TO BE CONSTRUED AS AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION WOULD BE ILLEGAL; AND (III) OTHER THAN DISCLOSURES RELATING TO THE NOMURA GROUP, BASED UPON INFORMATION FROM SOURCES THAT WE CONSIDER RELIABLE, BUT HAS NOT BEEN INDEPENDENTLY VERIFIED BY NOMURA GROUP. Other than disclosures relating to the Nomura Group, the Nomura Group does not warrant, represent or undertake, express or implied, that the document is fair, accurate, complete, correct, reliable or fit for any particular purpose or merchantable, and to the maximum extent permissible by law and/or regulation, does not accept liability (in negligence or otherwise, and in whole or in part) for any act (or decision not to act) resulting from use of this document and related data. To the maximum extent permissible by law and/or regulation, all warranties and other assurances by the Nomura Group are hereby excluded and the Nomura Group shall have no liability (in negligence or otherwise, and in whole or in part) for any loss howsoever arising from the use, misuse, or distribution of this material or the information contained in this material or otherwise arising in connection therewith. Opinions or estimates expressed are current opinions as of the original publication date appearing on this material and the information, including the opinions and estimates contained herein, are subject to change without notice. The Nomura Group, however, expressly disclaims any obligation, and therefore is under no duty, to update or revise this document. Any comments or statements made herein are those of the author(s) and may differ from views held by other parties within Nomura Group. Clients should consider whether any advice or recommendation in this report is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The Nomura Group does not provide tax advice. The Nomura Group, and/or its officers, directors, employees and affiliates, may, to the extent permitted by applicable law and/or regulation, deal as principal, agent, or otherwise, or have long or short positions in, or buy or sell, the securities, commodities or instruments, or options or other derivative instruments based thereon, of issuers or securities mentioned herein. The Nomura Group companies may also act as market maker or liquidity provider (within the meaning of applicable regulations in the UK) in the financial instruments of the issuer. Where the activity of market maker is carried out in accordance with the definition given to it by specific laws and regulations of the US or other jurisdictions, this will be separately disclosed within the specific issuer disclosures. This document may contain information obtained from third parties, including, but not limited to, ratings from credit ratings agencies such as Standard & Poor’s. The Nomura Group hereby expressly disclaims all representations, warranties or undertakings of originality, fairness, accuracy, completeness, correctness, merchantability or fitness for a particular purpose with respect to any of the information obtained from third parties contained in this material or otherwise arising in connection therewith, and shall not be liable (in negligence or otherwise, and in whole or in part) for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use or misuse of any of the information obtained from third parties contained in this material or otherwise arising in connection therewith. Reproduction and distribution of third-party content in any form is prohibited except with the prior written permission of the related third-party. Third-party content providers do not, express or implied, guarantee the fairness, accuracy, completeness, correctness, timeliness or availability of any information, including ratings, and are not in any way responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use or misuse of such content. Third-party content providers give no express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Third-party content providers shall not be liable (in negligence or otherwise, and in whole or in part) for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use or misuse of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Any MSCI sourced information in this document is the exclusive property of MSCI Inc. (‘MSCI’). Without prior written permission of MSCI, this information and any other MSCI intellectual property may not be duplicated, reproduced, re-disseminated, redistributed or used, in whole or in part, for any purpose whatsoever, including creating any financial products and any indices. This information is provided on an "as is" basis. The user assumes the entire risk of any use made of this information. MSCI, its affiliates and any third party involved in, or related to, computing or compiling the information hereby expressly disclaim all representations, warranties or undertakings of originality, fairness, accuracy, completeness, correctness, merchantability or fitness for a particular purpose with respect to any of this material or the information contained in this material or otherwise arising in connection therewith. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability (in negligence or otherwise, and in whole or in part) for any damages of any kind. MSCI and the MSCI indexes are services marks of MSCI and its affiliates. The intellectual property rights and any other rights, in Russell/Nomura Japan Equity Index belong to Nomura Fiduciary Research & Consulting Co., Ltd. ("NFRC") and FTSE Russell ("Russell"). NFRC and Russell do not guarantee fairness, accuracy, completeness, correctness, reliability, usefulness, marketability, merchantability or fitness of the Index, and do not account for business activities or services that any index user and/or its affiliates undertakes with the use of the Index. Investors should consider this document as only a single factor in making their investment decision and, as such, the report should not be viewed as identifying or suggesting all risks, direct or indirect, that may be associated with any investment decision. Nomura Group produces a number of different types of research product including, among others, fundamental analysis and quantitative analysis; recommendations contained in one type of research product may differ from recommendations contained in other types of research product, whether as a result of differing time horizons, methodologies or otherwise. The Nomura Group publishes research product in a number of different ways including the posting of product on the Nomura Group portals and/or distribution directly to clients. Different groups of clients may receive different products and services from the research department depending on their individual requirements. Figures presented herein may refer to past performance or simulations based on past performance which are not reliable indicators of future or likely performance. Where the information contains an expectation, projection or indication of future performance and business prospects, such forecasts may not be a reliable indicator of future or likely performance. Moreover, simulations are based on models and simplifying assumptions which may oversimplify and not reflect the future distribution of returns. Any figure, strategy or index created and published for illustrative purposes within this document is not intended for “use” as a “benchmark” as defined by the European Benchmark Regulation. Certain securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of, or income derived from, the investment. With respect to Fixed Income Research: Recommendations fall into two categories: tactical, which typically last up to three months; or strategic, which typically last from 6-12 months. However, trade recommendations may be reviewed at any time as circumstances change. ‘Stop loss’levels for trades are also provided; which, if hit, closes the trade recommendation automatically. Prices and yields shown in recommendations are taken at the time of submission for publication and are based on either indicative Bloomberg, LSEG or Nomura prices and yields at that time. The prices and yields shown are not necessarily those at which the trade recommendation can be implemented. The securities described herein may not have been registered under the US Securities Act of 1933 (the ‘1933 Act’), and, in such case, may not be offered or sold in the US or to US persons unless they have been registered under the 1933 Act, or except in compliance with an exemption from the registration requirements of the 1933 Act. Unless governing law permits otherwise, any transaction should be executed via a Nomura entity in your home jurisdiction. This document has been approved for distribution in the UK as investment research by NIplc. NIplc is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. NIplc is a member of the London Stock Exchange. This document does not constitute a personal recommendation within the meaning of applicable regulations in the UK, or take into account the particular investment objectives, financial situations, or needs of individual investors. This document is intended only for investors who are 'eligible counterparties' or 'professional clients' for the purposes of applicable regulations in the UK, and may not, therefore, be redistributed to persons who are 'retail clients' for such purposes. This document has been approved for distribution in the European Economic Area as investment research by Nomura Financial Products Europe GmbH (“NFPE”). NFPE is a company organized as a limited liability company under German law registered in the Commercial Register of the Court of Frankfurt/Main under HRB 110223. NFPE is authorized and regulated by the German Federal Financial Supervisory Authority (BaFin). This document has been approved by NIHK, which is regulated by the Hong Kong Securities and Futures Commission, for distribution in Hong Kong by NIHK. This document is intended only for investors who are 'professional investors' for the purposes of applicable regulations in Hong Kong and may not, therefore, be redistributed to persons who are not 'professional investors' for such purposes. This document has been approved for distribution in Australia by NAL, which is authorized and regulated in Australia by the ASIC. This document has also been approved for distribution in Malaysia by NSM. In Singapore, this document has been distributed by NSL, an exempt financial adviser as defined under the Financial Advisers Act (Chapter 110), among other things, and regulated by the Monetary Authority of Singapore. NSL may distribute this document produced by its foreign affiliates pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. This document is intended for accredited, expert or institutional investors as defined by the Securities and Futures Act (Chapter 289). Where the recipient of this document is not an accredited, expert or institutional investor, NSL accepts legal responsibility for the contents of this document in respect of such recipient only to the extent required by law. Recipients of this document in Singapore should contact NSL in respect of matters arising from, or in connection with, this document. THIS DOCUMENT IS INTENDED FOR GENERAL CIRCULATION. IT DOES NOT TAKE INTO ACCOUNT THE SPECIFIC INVESTMENT OBJECTIVES, FINANCIAL SITUATION OR PARTICULAR NEEDS OF ANY PARTICULAR PERSON. RECIPIENTS SHOULD TAKE INTO ACCOUNT THEIR SPECIFIC INVESTMENT OBJECTIVES, FINANCIAL SITUATION OR PARTICULAR NEEDS BEFORE MAKING A COMMITMENT TO PURCHASE ANY SECURITIES, INCLUDING SEEKING ADVICE FROM AN INDEPENDENT FINANCIAL ADVISER REGARDING THE SUITABILITY OF THE INVESTMENT, UNDER A SEPARATE ENGAGEMENT, AS THE RECIPIENT DEEMS FIT. Unless prohibited by the provisions of Regulation S of the 1933 Act, this material is distributed in the US, by NSI, a US-registered broker-dealer, which accepts responsibility for its contents in accordance with the provisions of Rule 15a-6, under the US Securities Exchange Act of 1934. The entity that prepared this document permits its separately operated affiliates within the Nomura Group to make copies of such documents available to their clients. This document has not been approved for distribution to persons other than ‘Authorised Persons’, ‘Exempt Persons’ or ‘Institutions’ (as defined by the Capital Markets Authority) in the Kingdom of Saudi Arabia (‘Saudi Arabia’) or a ’Market Counterparty’ or a 'Professional Client' (as defined by the Dubai Financial Services Authority) in the United Arab Emirates (‘UAE’) or a ‘Market Counterparty’ or a ‘Business Customer’ (as defined by the Qatar Financial Centre Regulatory Authority) in the State of Qatar (‘Qatar’) by Nomura Saudi Arabia, NIplc or any other member of the Nomura Group, as the case may be. Neither this document nor any copy thereof may be taken or transmitted or distributed, directly or indirectly, by any person other than those authorised to do so into Saudi Arabia or in the UAE or in Qatar or to any person other than ‘Authorised Persons’, ‘Exempt Persons’ or ‘Institutions’ located in Saudi Arabia or a ’Market Counterparty’ or a 'Professional Client' in the UAE or a ‘Market Counterparty’ or a ‘Business Customer’ in Qatar. Any failure to comply with these restrictions may constitute a violation of the laws of the UAE or Saudi Arabia or Qatar. For report with reference of TAIWAN public companies or authored by Taiwan based research analyst: THIS DOCUMENT IS SOLELY FOR REFERENCE ONLY. You should independently evaluate the investment risks and are solely responsible for your investment decisions. NO PORTION OF THE REPORT MAY BE REPRODUCED OR QUOTED BY THE PRESS OR ANY OTHER PERSON WITHOUT WRITTEN AUTHORIZATION FROM NOMURA GROUP. Pursuant to Operational Regulations Governing Securities Firms Recommending Trades in Securities to Customers and/or other applicable laws or regulations in Taiwan, you are prohibited to provide the reports to others (including but not limited to related parties, affiliated companies and any other third parties) or engage in any activities in connection with the reports which may involve conflicts of interests. INFORMATION ON SECURITIES / INSTRUMENTS NOT EXECUTABLE BY NOMURA INTERNATIONAL (HONG KONG) LTD., TAIPEI BRANCH IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT BE CONSTRUED AS A RECOMMENDATION OR A SOLICITATION TO TRADE IN SUCH SECURITIES / INSTRUMENTS. This material may not be distributed in Indonesia or passed on within the territory of the Republic of Indonesia or to persons who are Indonesian citizens (wherever they are domiciled or located) or entities of or residents in Indonesia in a manner which constitutes a public offering under the laws of the Republic of Indonesia. The securities mentioned in this document may not be offered or sold in Indonesia or to persons who are citizens of Indonesia (wherever they are domiciled or located) or entities of or residents in Indonesia in a manner which constitutes a public offering under the laws of the Republic of Indonesia. An individual name printed next to NOI on the front page of a research report indicates that this document is a translation of a research report issued by NOI in the PRC. In all other cases, this document is prepared by Nomura Group or its subsidiary or affiliate (collectively, “Offshore Issuers”) that is not licensed in the PRC to provide securities research. This research report is not approved or intended to be circulated in the PRC. The A-share related analysis (if any) is not produced for any persons located or incorporated in the PRC. The recipients should not rely on any information contained in this research report in making investment decisions and Offshore Issuers take no responsibility in this regard. NO PART OF THIS MATERIAL MAY BE (I) COPIED, PHOTOCOPIED, REPRODUCED OR DUPLICATED IN ANY FORM, BY ANY MEANS; OR (II) REDISSEMINATED, REPUBLISHED OR REDISTRIBUTED WITHOUT THE PRIOR WRITTEN CONSENT OF A MEMBER OF THE NOMURA GROUP. If this document has been distributed by electronic transmission, such as e-mail, then such transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability (in negligence or otherwise, and in whole or in part) for any errors or omissions in the contents of this document, which may arise as a result of electronic transmission. If verification is required, please request a hard-copy version.
The Nomura Group manages conflicts with respect to the production of research through its compliance policies and procedures (including, but not limited to, Conflicts of Interest, Chinese Wall and Confidentiality policies) as well as through the maintenance of Chinese Walls and employee training. Additional information regarding the methodologies or models used in the production of any investment recommendations contained within this document is available upon request by contacting the Research Analysts of Nomura listed on the front page. Disclosures information is available upon request and disclosure information is available at the Nomura Disclosure web page: http://go.nomuranow.com/research/m/Disclosures Copyright © 2026 Nomura Singapore Ltd., Singapore. All rights reserved.